11/10/2026
A Clinical Trial Site Is Delayed. Who Owns the Decisions Needed to Move Forward?
Site activation often requires coordination across Clinical Operations, Regulatory Affairs, Contracts, and other stakeholders.
When delays lead to multiple review meetings, are decisions, escalations, and follow-up commitments clearly connected?
Unified Meeting Suite (UMS) connects meeting decisions, assigned actions, and follow-up across related site activation reviews.
This helps Clinical Operations leaders maintain visibility into cross-functional ownership and outstanding commitments.
Because resolving site activation delays requires coordinated decisions, not just identifying bottlenecks.
Want to explore UMS for clinical operations governance? Request a focused demonstration.